Comparing antibody and small-molecule therapies for cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16929325.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The 'magic bullet' concept of specifically targeting cancer cells at the same time as sparing normal tissues is now proven, as several monoclonal antibodies and targeted small-molecule compounds have been approved for cancer treatment. Both antibodies and small-molecule compounds are therefore promising tools for target-protein-based cancer therapy. We discuss and compare the distinctive properties of these two therapeutic strategies so as to provide a better view for the development of new drugs and the future direction of cancer therapy.
Medical subject headings
- Antibodies, Monoclonal
- Antineoplastic Agents
- Drugs, Investigational
- Neoplasms